Create a free research account to view current pricing and place an order.
Mechanism of action
Tesamorelin is a synthetic GHRH analog that activates pituitary GHRH receptors to increase pulsatile GH output and downstream IGF-1 signaling. It is mechanistically upstream of direct GH exposure. Ipamorelin is a selective ghrelin receptor/GHSR agonist researched for GH pulse support with comparatively lower prolactin and cortisol signaling than older GHRPs.
Half-life & pharmacokinetics
Half-life: Blend; components differ.
Blend pharmacokinetics vary by component. Operational timing should be based on the dominant pathway and the most sensitivity-prone ingredient.
Research dosing reference
10-20 units daily provides a practical blended GH-axis exposure range; component ratio should be considered.
Reconstitution & concentration
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 11/6 mg | 2 mL BAC Water | 0.085 mg/unit total blend |
Injection timing
Often used before bed or during fasted windows to align with GH-axis signaling and reduce food-related interference.
Beginner escalation
Begin conservatively while monitoring hunger, edema, sleep quality, glucose response, and tingling/carpal-tunnel-like symptoms.
Side-effect mitigation
Monitor water retention, increased hunger, flushing, glucose variability, joint stiffness, or tingling. Periodic IGF-1 and glucose monitoring may be appropriate in longer protocols.
Stack compatibility
GH-axis agents stack most logically with complementary GH secretagogues; avoid overbuilding GH-axis stacks without monitoring IGF-1, glucose, and edema response.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
GH-axis protocols should reassess every 8-12 weeks: IGF-1, fasting glucose/A1c where appropriate, edema, sleep quality, hunger, body-composition objectives, and continued need.
Frequently asked questions
What is Tesamorelin/Ipamorelin Blend and how does it work?
Tesamorelin is a synthetic GHRH analog that activates pituitary GHRH receptors to increase pulsatile GH output and downstream IGF-1 signaling. It is mechanistically upstream of direct GH exposure. Ipamorelin is a selective ghrelin receptor/GHSR agonist researched for GH pulse support with comparatively lower prolactin
What is the half-life of Tesamorelin/Ipamorelin Blend?
Tesamorelin/Ipamorelin Blend: Blend; components differ. Blend pharmacokinetics vary by component. Operational timing should be based on the dominant pathway and the most sensitivity-prone ingredient.
How is Tesamorelin/Ipamorelin Blend reconstituted for research?
Preferred reconstitution for the 11/6 mg vial is 2 mL BAC Water, giving 0.085 mg/unit total blend. Always confirm concentration math before any use. Research use only.
Is Tesamorelin/Ipamorelin Blend FDA approved?
No. Tesamorelin/Ipamorelin Blend is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration